NICM
PFE icon

Neo Ivy Capital Management’s Pfizer PFE Stock Holding History

Neo Ivy Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
+144,562
New +$3.78M 0.8% 28
2026
Q1 		– Sell
-140,529
Closed -$3.5M – 463
2025
Q4 		$3.5M Buy
140,529
+101,383
+259% +$2.56M 0.55% 73
2025
Q3 		$997K Sell
39,146
-82,138
-68% -$2.03M 0.24% 143
2025
Q2 		$2.94M Buy
121,284
+43,542
+56% +$1.02M 0.94% 14
2025
Q1 		$1.97M Sell
77,742
-62,715
-45% -$1.64M 0.63% 69
2024
Q4 		$3.73M Buy
140,457
+63,289
+82% +$1.72M 0.75% 31
2024
Q3 		$2.23M Buy
77,168
+71,500
+1,261% +$2.09M 0.72% 49
2024
Q2 		$159K Buy
+5,668
New +$156K 0.03% 197
2023
Q4 		– Sell
-19,328
Closed -$641K – 419
2023
Q3 		$641K Buy
+19,328
New +$683K 0.28% 115
2022
Q3 		– Sell
-1,554
Closed -$81K – 505
2022
Q2 		$81K Sell
1,554
-6,126
-80% -$312K 0.22% 172
2022
Q1 		$398K Buy
+7,680
New +$398K 0.36% 97
2021
Q4 		– Sell
-24,668
Closed -$807K – 584
2021
Q3 		$807K Buy
24,668
+5,893
+31% +$261K 0.93% 3
2021
Q2 		$735K Buy
18,775
+14,045
+297% +$546K 0.74% 31
2021
Q1 		$171K Buy
+4,730
New +$168K 0.19% 177
2020
Q4 		– Sell
-19,156
Closed -$667K – 539
2020
Q3 		$667K Sell
19,156
-6,844
-26% -$240K 0.67% 21
2020
Q2 		$807K Buy
+26,000
New +$883K 0.93% 3
2019
Q2 		– Sell
-5,050
Closed -$203K – 377
2019
Q1 		$203K Buy
+5,050
New +$202K 0.12% 199

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Neo Ivy Capital Management's PFE Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Pfizer (PFE) in Q2 2026: 144,562 shares worth $3.48M. The stake represents 0.8% of the portfolio and ranks #28 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in PFE as recently as Q4 2025.

Neo Ivy Capital Management first reported a position in PFE in Q1 2019 and has held it in 17 quarters since. The position peaked at $3.73M in Q4 2024. 2,838 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Neo Ivy Capital Management held 144,562 shares of Pfizer worth $3.48M as of Q2 2026.
  • Pfizer was a new Neo Ivy Capital Management position in Q2 2026.
  • Pfizer made up 0.8% of Neo Ivy Capital Management's portfolio in Q2 2026, its #28 holding.
  • Neo Ivy Capital Management first reported a position in Pfizer in Q1 2019 and has held it in 17 quarters since.
  • Neo Ivy Capital Management's Pfizer position peaked at $3.73M in Q4 2024.
  • 2,838 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.